Role of SIRT1 in regulation of epithelial-to-mesenchymal transition in oral squamous cell carcinoma metastasis

[1]  A. Mäkitie,et al.  Matrix metalloproteinase‐7 and matrix metalloproteinase‐25 in oral tongue squamous cell carcinoma , 2014, Head & neck.

[2]  H. Chiang,et al.  Role of SIRT1 in regulation of epithelial-to-mesenchymal transition in oral squamous cell carcinoma metastasis , 2014, Molecular Cancer.

[3]  Tie-jun Li,et al.  COX-2, MMP-7 expression in oral lichen planus and oral squamous cell carcinoma. , 2013, Asian Pacific journal of tropical medicine.

[4]  D. Leprince,et al.  A SUMOylation-dependent pathway regulates SIRT1 transcription and lung cancer metastasis. , 2013, Journal of the National Cancer Institute.

[5]  L. Guarente,et al.  SIRT1 suppresses the epithelial-to-mesenchymal transition in cancer metastasis and organ fibrosis. , 2013, Cell reports.

[6]  K. Uzawa,et al.  Exocyst complex component Sec8: a presumed component in the progression of human oral squamous-cell carcinoma by secretion of matrix metalloproteinases , 2013, Journal of Cancer Research and Clinical Oncology.

[7]  D. Faller,et al.  SIRT1 induces EMT by cooperating with EMT transcription factors and enhances prostate cancer cell migration and metastasis , 2012, Oncogene.

[8]  C. Heldin,et al.  Induction of epithelial-mesenchymal transition by transforming growth factor β. , 2012, Seminars in cancer biology.

[9]  H. Sakurai,et al.  SRT1720, a SIRT1 activator, promotes tumor cell migration, and lung metastasis of breast cancer in mice. , 2012, Oncology reports.

[10]  T. Yen,et al.  Neck dissection field and lymph node density predict prognosis in patients with oral cavity cancer and pathological node metastases treated with adjuvant therapy. , 2012, Oral oncology.

[11]  T. Holyoake,et al.  Activation of p53 by SIRT1 inhibition enhances elimination of CML leukemia stem cells in combination with imatinib. , 2012, Cancer cell.

[12]  Michael J. Wilson,et al.  miR‐520c and miR‐373 upregulate MMP9 expression by targeting mTOR and SIRT1, and activate the Ras/Raf/MEK/Erk signaling pathway and NF‐κB factor in human fibrosarcoma cells , 2012, Journal of cellular physiology.

[13]  M. Nieto,et al.  The ins and outs of the epithelial to mesenchymal transition in health and disease. , 2011, Annual review of cell and developmental biology.

[14]  King-Jen Chang,et al.  Dimerumic Acid Inhibits SW620 Cell Invasion by Attenuating H2O2-Mediated MMP-7 Expression via JNK/C-Jun and ERK/C-Fos Activation in an AP-1-Dependent Manner , 2011, International journal of biological sciences.

[15]  Qun Zhou,et al.  miR-200a Regulates SIRT1 Expression and Epithelial to Mesenchymal Transition (EMT)-like Transformation in Mammary Epithelial Cells* , 2011, The Journal of Biological Chemistry.

[16]  Byoung Kil Lee,et al.  Expression of DBC1 and SIRT1 is associated with poor prognosis for breast carcinoma. , 2011, Human pathology.

[17]  J. Bertram,et al.  Resveratrol inhibits renal fibrosis in the obstructed kidney: potential role in deacetylation of Smad3. , 2010, The American journal of pathology.

[18]  I. Pogribny,et al.  E‐cadherin transcriptional down‐regulation by epigenetic and microRNA‐200 family alterations is related to mesenchymal and drug‐resistant phenotypes in human breast cancer cells , 2010, International journal of cancer.

[19]  Robert A. Weinberg,et al.  The basics of epithelial-mesenchymal transition. , 2009, The Journal of clinical investigation.

[20]  L. Guarente,et al.  Aging and disease: connections to sirtuins , 2010, Aging cell.

[21]  A. Pintzas,et al.  Epithelial-mesenchymal transition in cancer metastasis: mechanisms, markers and strategies to overcome drug resistance in the clinic. , 2009, Biochimica et biophysica acta.

[22]  T. Nakao,et al.  Effects of liposome clodronate on renal leukocyte populations and renal fibrosis in murine obstructive nephropathy. , 2009, Journal of pharmacological sciences.

[23]  Bhavneet Kaur.  Evaluation of oral health awareness in parents of preschool children. , 2009, Indian journal of dental research : official publication of Indian Society for Dental Research.

[24]  M. Mann,et al.  Lysine Acetylation Targets Protein Complexes and Co-Regulates Major Cellular Functions , 2009, Science.

[25]  G. Rangan,et al.  Disruption of E-cadherin by matrix metalloproteinase directly mediates epithelial-mesenchymal transition downstream of transforming growth factor-beta1 in renal tubular epithelial cells. , 2009, The American journal of pathology.

[26]  C. Tzao,et al.  Distinct HIC1-SIRT1-p53 loop deregulation in lung squamous carcinoma and adenocarcinoma patients. , 2009, Neoplasia.

[27]  R. Crystal,et al.  A SNAIL1–SMAD3/4 transcriptional repressor complex promotes TGF-β mediated epithelial–mesenchymal transition , 2009, Nature Cell Biology.

[28]  C. Deng,et al.  Recent progress in the biology and physiology of sirtuins , 2009, Nature.

[29]  K. Jang,et al.  Expression of DBC1 and SIRT1 Is Associated with Poor Prognosis of Gastric Carcinoma , 2009, Clinical Cancer Research.

[30]  Raghu Kalluri,et al.  The basics of epithelial-mesenchymal transition. , 2009, The Journal of clinical investigation.

[31]  S. Warnakulasuriya.  Global epidemiology of oral and oropharyngeal cancer. , 2009, Oral oncology.

[32]  G. Marshall,et al.  The critical role of the class III histone deacetylase SIRT1 in cancer. , 2009, Cancer research.

[33]  Samy Lamouille,et al.  TGF-β-induced epithelial to mesenchymal transition , 2009, Cell Research.

[34]  G. Sonenshein,et al.  The Lysyl Oxidase Pro-peptide Attenuates Fibronectin-mediated Activation of Focal Adhesion Kinase and p130Cas in Breast Cancer Cells* , 2009, Journal of Biological Chemistry.

[35]  N. Rao,et al.  Expression of E-cadherin in primary oral squamous cell carcinoma and metastatic lymph nodes: an immunohistochemical study. , 2009, Indian journal of dental research : official publication of Indian Society for Dental Research.

[36]  M. Aoki,et al.  Matrix metalloproteinase 7 is required for tumor formation, but dispensable for invasion and fibrosis in SMAD4-deficient intestinal adenocarcinomas , 2009, Laboratory Investigation.

[37]  Gerhard Christofori,et al.  EMT, the cytoskeleton, and cancer cell invasion , 2009, Cancer and Metastasis Reviews.

[38]  M. Ott,et al.  The ups and downs of SIRT1. , 2008, Trends in biochemical sciences.

[39]  X. Wang,et al.  Impaired DNA damage response, genome instability, and tumorigenesis in SIRT1 mutant mice. , 2008, Cancer cell.

[40]  K. Jang,et al.  SIRT1 Expression is Associated With Poor Prognosis of Diffuse Large B-Cell Lymphoma , 2008, The American journal of surgical pathology.

[41]  A. Kazantsev,et al.  Biological and Potential Therapeutic Roles of Sirtuin Deacetylases , 2008, Cellular and Molecular Life Sciences.

[42]  T. Yen,et al.  Head and neck cancer in the betel quid chewing area: recent advances in molecular carcinogenesis , 2008, Cancer science.

[43]  S. Dimmeler,et al.  Emerging roles of SIRT1 in vascular endothelial homeostasis , 2008, Cell cycle.

[44]  Buzz Baum,et al.  Transitions between epithelial and mesenchymal states in development and disease. , 2008, Seminars in cell & developmental biology.

[45]  E. Lander,et al.  Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. , 2008, Cancer research.

[46]  D. Faller,et al.  Transcription Regulation by Class III Histone Deacetylases (HDACs)—Sirtuins , 2008, Translational oncogenomics.

[47]  W. Hahn,et al.  The SIRT1 Deacetylase Suppresses Intestinal Tumorigenesis and Colon Cancer Growth , 2008, PloS one.

[48]  L. Guarente.  Sirtuins in aging and disease. , 2007, Cold Spring Harbor symposia on quantitative biology.

[49]  M. Salto‐Tellez,et al.  Function of the SIRT1 protein deacetylase in cancer. , 2007, Biotechnology journal.

[50]  Y. Ouchi,et al.  Sirt1 modulates premature senescence-like phenotype in human endothelial cells. , 2007, Journal of molecular and cellular cardiology.

[51]  Lu Li,et al.  Downregulation of Sirt1 by antisense oligonucleotides induces apoptosis and enhances radiation sensitization in A549 lung cancer cells. , 2007, Lung cancer.

[52]  C. Heldin,et al.  Signaling networks guiding epithelial–mesenchymal transitions during embryogenesis and cancer progression , 2007, Cancer science.

[53]  Kohei Miyazono,et al.  Differential Regulation of Epithelial and Mesenchymal Markers by δEF1 Proteins in Epithelial–Mesenchymal Transition Induced by TGF-β , 2007 .

[54]  T. Nagy,et al.  Erratum: SIRT1 is significantly elevated in mouse and human prostate cancer (Cancer Research (2007) 67, (6612-6618)) , 2007 .

[55]  E. Verdin,et al.  Sirtuins: critical regulators at the crossroads between cancer and aging , 2007, Oncogene.

[56]  J. Auwerx,et al.  Sirtuin functions in health and disease. , 2007, Molecular endocrinology.

[57]  P. Lequerica-Fernández,et al.  Expression of MMP-7 and MT1-MMP in oral squamous cell carcinoma as predictive indicator for tumor invasion and prognosis. , 2007, Journal of Oral Pathology & Medicine.

[58]  Connie Wang,et al.  Transforming Growth Factor-β1 Induces an Epithelial-to-Mesenchymal Transition State in Mouse Hepatocytes in Vitro* , 2007, Journal of Biological Chemistry.

[59]  T. Nagy,et al.  SIRT1 is significantly elevated in mouse and human prostate cancer. , 2007, Cancer research.

[60]  E. Nkenke,et al.  High gene expression of matrix metalloproteinase-7 is associated with early stages of oral cancer. , 2007, Anticancer research.

[61]  S. Shukla,et al.  Clinical significance of MMP‐2 and MMP‐9 in patients with oral cancer , 2007, Head & neck.

[62]  A. Menke,et al.  Signaling Pathways Involved in Collagen-Induced Disruption of the E-Cadherin Complex during Epithelial-Mesenchymal Transition , 2007, Cells Tissues Organs.

[63]  Héctor Peinado,et al.  Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? , 2007, Nature Reviews Cancer.

[64]  David Sinclair,et al.  Sirtuins in mammals: insights into their biological function. , 2007, The Biochemical journal.

[65]  L. Guarente,et al.  SIRT1 Inhibits Transforming Growth Factor β-Induced Apoptosis in Glomerular Mesangial Cells via Smad7 Deacetylation* , 2007, Journal of Biological Chemistry.

[66]  N. Enomoto,et al.  Smad4 is essential for down-regulation of E-cadherin induced by TGF-beta in pancreatic cancer cell line PANC-1. , 2006, Journal of biochemistry.

[67]  Kohei Miyazono,et al.  Differential regulation of epithelial and mesenchymal markers by deltaEF1 proteins in epithelial mesenchymal transition induced by TGF-beta. , 2007, Molecular biology of the cell.

[68]  T. Nagy,et al.  SIRT 1 Is Significantly Elevated in Mouse and Human Prostate Cancer , 2007 .

[69]  Y. Kubo,et al.  Strong expression of a longevity-related protein, SIRT1, in Bowen’s disease , 2007, Archives of Dermatological Research.

[70]  L. Guarente,et al.  Mammalian sirtuins--emerging roles in physiology, aging, and calorie restriction. , 2006, Genes & development.

[71]  Y. Jinbu,et al.  Increased expression and activation of matrix metalloproteinase-2 (MMP-2) in O-1N: hamster oral squamous cell carcinoma with high potential lymph node metastasis. , 2006, Journal of experimental & clinical cancer research : CR.

[72]  P. ten Dijke,et al.  The tumor suppressor Smad4 is required for transforming growth factor beta-induced epithelial to mesenchymal transition and bone metastasis of breast cancer cells. , 2006, Cancer research.

[73]  Kelly M. McGarvey,et al.  Inhibition of SIRT1 Reactivates Silenced Cancer Genes without Loss of Promoter DNA Hypermethylation , 2006, PLoS genetics.

[74]  J. Thiery,et al.  Complex networks orchestrate epithelial–mesenchymal transitions , 2006, Nature Reviews Molecular Cell Biology.

[75]  Michaell A. Huber,et al.  Squamous cell carcinoma of the oral tissues: a comprehensive review for oral healthcare providers. , 2005, The journal of contemporary dental practice.

[76]  Izumi Horikawa,et al.  Evolutionarily conserved and nonconserved cellular localizations and functions of human SIRT proteins. , 2005, Molecular biology of the cell.

[77]  C. Heldin,et al.  TGF-beta and the Smad signaling pathway support transcriptomic reprogramming during epithelial-mesenchymal cell transition. , 2005, Molecular biology of the cell.

[78]  L. Guarente,et al.  Calorie restriction, SIRT1 and metabolism: understanding longevity , 2005, Nature Reviews Molecular Cell Biology.

[79]  Tzong-Ming Shieh,et al.  Genome‐wide profiling of oral squamous cell carcinoma , 2004, The Journal of pathology.

[80]  Y. Kudo,et al.  Invasion and Metastasis of Oral Cancer Cells Require Methylation of E-Cadherin and/or Degradation of Membranous β-Catenin , 2004, Clinical Cancer Research.

[81]  L. Partridge,et al.  The interaction between FOXO and SIRT1: tipping the balance towards survival. , 2004, Trends in cell biology.

[82]  Myriam Gorospe,et al.  Calorie Restriction Promotes Mammalian Cell Survival by Inducing the SIRT1 Deacetylase , 2004, Science.

[83]  Steven P. Gygi,et al.  Stress-Dependent Regulation of FOXO Transcription Factors by the SIRT1 Deacetylase , 2004, Science.

[84]  F. Bertucci,et al.  Immunophenotypic analysis of inflammatory breast cancers: identification of an ‘inflammatory signature’ , 2004, The Journal of pathology.

[85]  Shu-Chun Lin,et al.  Establishment of OC3 oral carcinoma cell line and identification of NF-kappa B activation responses to areca nut extract. , 2004, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[86]  Gerhard Christofori,et al.  Cell adhesion and signalling by cadherins and Ig-CAMs in cancer , 2004, Nature Reviews Cancer.

[87]  T. Shiomi,et al.  MT1-MMP and MMP-7 in invasion and metastasis of human cancers , 2003, Cancer and Metastasis Reviews.

[88]  Jean Paul Thiery,et al.  Epithelial-mesenchymal transitions in development and pathologies. , 2003, Current opinion in cell biology.

[89]  L. Guarente,et al.  Nicotinamide adenine dinucleotide, a metabolic regulator of transcription, longevity and disease. , 2003, Current opinion in cell biology.

[90]  K. Maclennan,et al.  Prognostic significance of microscopic and macroscopic extracapsular spread from metastatic tumor in the cervical lymph nodes. , 2002, Oral oncology.

[91]  Jeffrey S. Smith.  Human Sir2 and the 'silencing' of p53 activity. , 2002, Trends in cell biology.

[92]  Tien-Yu Shieh,et al.  The incidence of oropharyngeal cancer in Taiwan: an endemic betel quid chewing area. , 2002, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[93]  C. Meyer.  Survival Under Stress , 2002 .

[94]  R. Weinberg,et al.  hSIR2SIRT1 Functions as an NAD-Dependent p53 Deacetylase , 2001, Cell.

[95]  Delin Chen,et al.  Negative Control of p53 by Sir2α Promotes Cell Survival under Stress , 2001, Cell.

[96]  P. Savagner,et al.  Leaving the neighborhood: molecular mechanisms involved during epithelial‐mesenchymal transition , 2001, BioEssays : news and reviews in molecular, cellular and developmental biology.

[97]  R. C. Chang,et al.  In vitro cellular response of retinoic acid treated human oral cancer cell lines. , 2001, Zhonghua yi xue za zhi = Chinese medical journal; Free China ed.

[98]  L. Guarente,et al.  Negative control of p53 by Sir2alpha promotes cell survival under stress. , 2001, Cell.

[99]  M. Mareel,et al.  Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1. , 2001, Journal of cell science.

[100]  L. Guarente,et al.  Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase , 2000, Nature.

[101]  H. Takeuchi,et al.  Expression of MMPS, MT‐MMP, and TIMPs in squamous cell carcinoma of the oral cavity: Correlations with tumor invasion and metastasis , 1999, Head & neck.

[102]  F. Watt,et al.  Comparison of integrin, cadherin, and catenin expression in squamous cell carcinomas of the oral cavity , 1998, The Journal of pathology.

[103]  A. Nagafuchi,et al.  Aberrant E-cadherin and alpha-catenin expression in prostate cancer: correlation with patient survival. , 1997, Cancer research.

[104]  S. Lippman,et al.  Head and Neck Cancer , 1993, Cancer Treatment and Research.

[105]  J. Bosq,et al.  Lymph node prognostic factors in head and neck squamous cell carcinomas. , 1994, American journal of surgery.

[106]  J. Ross,et al.  E-cadherin expression in prostatic carcinoma biopsies: correlation with tumor grade, DNA content, pathologic stage, and clinical outcome. , 1994, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[107]  D. Ruiter,et al.  E‐cadherin expression in head and neck squamous‐cell carcinoma is associated with clinical outcome , 1993, International journal of cancer.

[108]  S. Taylor.  Head and neck cancer. , 1991, Cancer chemotherapy and biological response modifiers.